Member Biography

Dr. Skaar’s research is focused on the discovery and implementation of genomic predictors of drug response. The discovery studies include identifying genetic variants that are associated with clinical drug efficacy and toxicity. Those variants are followed up with laboratory functional studies to understand the mechanisms underlying their association. This also includes identifying miRNAs that contribute to the developmental changes in hepatic drug metabolism. The implementation studies include prospectively testing and using pharmacogenetic testing in clinical care.

Post-doctoral Fellowship - Georgetown University 1992-1997

Ph.D. - Pennsylvania State University 1988-1992